Headaches in people with MOGAD
Part of Brain & nervous system, Immune system & allergy, Pain clinical trials.
This study looks at how common headaches are in people with MOGAD and what type of headaches they have. It aims to help doctors better understand and manage headaches in this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have a diagnosis of MOGAD (a condition where your immune system attacks a protein on nerve cells, causing inflammation).
- You must be able to understand and sign a consent form to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a specific gene change in people with MS, NMOSD, or MOGAD to see how common it is. By joining, you help researchers learn more about these conditions and possible future treatments.
This study looks at the early signs that happen before a migraine starts, such as fatigue or mood changes. It aims to help people understand their migraine patterns better.
This study builds a China-based group of people with neuroinflammatory and demyelination diseases and collects health and MRI (brain scan) information. It may help doctors better understand these conditions over time and improve future treatments.
This study looks at tear samples to find biomarkers that could help diagnose migraine. It involves people with migraine and healthy volunteers.
This study is a headache disorder registry that enrolls people with common, “primary” headache types such as migraine or tension headache, including some with medication-overuse headaches. It collects information to better understand these conditions and who they affect.
This trial tests a minimally invasive procedure that blocks a blood vessel in the brain to reduce migraine attacks. It may help people who have frequent migraines and haven't found relief with standard migraine medications.
Hear when a new MOGAD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.